Atypical Mycobacteria in Bronchiectasis. When do we Treat it?
Arch Bronconeumol (Engl Ed). 2019 Apr;55(4):183-184.
doi: 10.1016/j.arbres.2018.10.007.
Epub 2018 Nov 22.
[Article in
English,
Spanish]
Affiliations
- 1 Hospital Universitari Vall d'Hebron (HUVH), Institut de Recerca Vall d'Hebron (VHIR), Barcelona, España.
- 2 Department of Medicine and Surgery, Respiratory Diseases, Università dell'Insubria, Varese-Como, Italia.
- 3 Hospital Universitari Vall d'Hebron (HUVH), Institut de Recerca Vall d'Hebron (VHIR), Barcelona, España; Servicio de Neumología, Hospital Universitari Vall d'Hebron (HUVH), CIBER, Barcelona, España. Electronic address: eva.polverino@vhir.org.
No abstract available
MeSH terms
-
Anti-Bacterial Agents / therapeutic use
-
Bronchiectasis / drug therapy
-
Bronchiectasis / microbiology*
-
Clinical Decision-Making
-
Humans
-
Mycobacterium Infections, Nontuberculous / complications*
-
Mycobacterium Infections, Nontuberculous / drug therapy